264 related articles for article (PubMed ID: 6498699)
21. Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions.
Caballero ML; Krantz MS; Quirce S; Phillips EJ; Stone CA
J Allergy Clin Immunol Pract; 2021 Aug; 9(8):2968-2982. PubMed ID: 33737254
[TBL] [Abstract][Full Text] [Related]
22. [Prohibit coloring agents in drugs].
Berglund F
Lakartidningen; 2004 Feb; 101(7):615. PubMed ID: 15024882
[No Abstract] [Full Text] [Related]
23. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
[TBL] [Abstract][Full Text] [Related]
24. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
25. Place of excipients in systemic drug allergy.
Barbaud A
Immunol Allergy Clin North Am; 2014 Aug; 34(3):671-9, x. PubMed ID: 25017684
[TBL] [Abstract][Full Text] [Related]
26. Rectal administration of drugs.
Senior N
Adv Pharm Sci; 1974; 4():363-435. PubMed ID: 4618035
[No Abstract] [Full Text] [Related]
27. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse.
Moench TR; Mumper RJ; Hoen TE; Sun M; Cone RA
BMC Infect Dis; 2010 Nov; 10():331. PubMed ID: 21087496
[TBL] [Abstract][Full Text] [Related]
28. Excipients in Anesthesia Medications.
Burbridge MA; Jaffe RA
Anesth Analg; 2019 May; 128(5):891-900. PubMed ID: 29505449
[TBL] [Abstract][Full Text] [Related]
29. Issues in the formulation of drugs for oral use in children: role of excipients.
Pawar S; Kumar A
Paediatr Drugs; 2002; 4(6):371-9. PubMed ID: 12038873
[TBL] [Abstract][Full Text] [Related]
30. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
31. Excipients in medicinal products used in gastroenterology as a possible cause of side effects.
Ursino MG; Poluzzi E; Caramella C; De Ponti F
Regul Toxicol Pharmacol; 2011 Jun; 60(1):93-105. PubMed ID: 21354240
[TBL] [Abstract][Full Text] [Related]
32. Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals.
Thompson DO
Crit Rev Ther Drug Carrier Syst; 1997; 14(1):1-104. PubMed ID: 9043816
[TBL] [Abstract][Full Text] [Related]
33. User unfriendly drugs--fillers, additives, excipients.
Shader RI; Greenblatt DJ
J Clin Psychopharmacol; 1985 Aug; 5(4):A15-6. PubMed ID: 4019808
[No Abstract] [Full Text] [Related]
34. Additives in medicine.
Marfatia YS; Kuttan SP
J Indian Med Assoc; 1997 Feb; 95(2):63. PubMed ID: 9357252
[No Abstract] [Full Text] [Related]
35. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products.
Glass BD; Haywood A
J Pharm Pharm Sci; 2006; 9(3):398-426. PubMed ID: 17207422
[TBL] [Abstract][Full Text] [Related]
36. Anaphylaxis to macrogol 4000 after a parenteral corticoid injection.
Dewachter P; Mouton-Faivre C
Allergy; 2005 May; 60(5):705-6. PubMed ID: 15813822
[No Abstract] [Full Text] [Related]
37. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
Wysowski DK; Swartz L
Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
[TBL] [Abstract][Full Text] [Related]
38. Extemporaneous drug formulations.
Nahata MC; Allen LV
Clin Ther; 2008 Nov; 30(11):2112-9. PubMed ID: 19108799
[TBL] [Abstract][Full Text] [Related]
39. Disposition of polyoxyethylated excipients in humans: implications for drug safety and formulation approaches.
Ten Tije AJ; Loos WJ; Verweij J; Baker SD; Dinh K; Figg WD; Sparreboom A
Clin Pharmacol Ther; 2003 Nov; 74(5):509-10. PubMed ID: 14586392
[No Abstract] [Full Text] [Related]
40. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
